NEW YORK--(BUSINESS WIRE)--The board of directors of Pfizer Inc. today declared a 28-cent fourth-quarter 2015 dividend on the company’s common stock, payable December 1, 2015, to shareholders of record at the close of business on November 6, 2015. The fourth-quarter 2015 cash dividend will be the 308th consecutive quarterly dividend paid by Pfizer.
About Pfizer Inc.
At Pfizer, we apply science and our global resources to bring therapies to people that extend and significantly improve their lives. We strive to set the standard for quality, safety and value in the discovery, development and manufacture of health care products. Our global portfolio includes medicines and vaccines as well as many of the world’s best-known consumer health care products. Every day, Pfizer colleagues work across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases of our time. Consistent with our responsibility as one of the world’s premier innovative biopharmaceutical companies, we collaborate with health care providers, governments and local communities to support and expand access to reliable, affordable health care around the world. For more than 150 years, Pfizer has worked to make a difference for all who rely on us. To learn more, please visit us at www.pfizer.com.
Contacts
Pfizer Inc.
Media:
Joan Campion, 212-733-2798
or
Investors:
Ryan Crowe, 212-733-8160
Help employers find you! Check out all the jobs and post your resume.
